Research
Metabolic adaptation
Patients in the semaglutide group experienced greater weight loss compared to the control group (−8.2% vs. −4.6%; P <0.001).
Semaglutide may be effective for weight management in patients post-ablation.
StrongSupportsmedium confidence
During the 12-month follow-up, the semaglutide group showed greater weight loss (−8.2% [3.2] versus −4.6% [2.9]; P <0.001).
Why this rating
The study is a prospective cohort with a significant sample size.
Source
Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study
Jiongchao Guo et al. · Circulation Arrhythmia and Electrophysiology · 2025
cohort · n=437Cited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →